logo

For the Inventor, By the Inventor

Marburg, Germany

Volkmar Gunzler-Pukall

USPTO Granted Patents = 8

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 74(Granted Patents)


Company Filing History:

goldMedal8 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1992-1997

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5679583 - Monoclonal antibodies for the selective immunological determination of (1997-10-21),
2. 5519038 - N,N'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamines (1996-05-21),
3. 5482953 - 2,4-and 2,5-bistetrazolylpyridines and the use thereof as pharmaceuticals (1996-01-09),
4. 5428046 - Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and (1995-06-27),
5. 5260323 - 2,4- and 2,5-substituted pyridine-N-oxides, processes for their (1993-11-09),
6. 5240921 - Cyclic pyridine-2,4- and -2,5-dicarboxylic acid diamides, processes for (1993-08-31),
7. 5204338 - Oxalylamino acid derivatives and their use as medicaments for inhibiting (1993-04-20),
8. 5130317 - Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use (1992-07-14),

Title: The Innovations of Volkmar Gunzler-Pukall

Introduction

Volkmar Gunzler-Pukall is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies and other innovative compounds. With a total of eight patents to his name, his work has had a considerable impact on medical diagnostics and therapeutic applications.

Latest Patents

One of his latest patents involves the use of monoclonal antibodies for the selective immunological determination of procollagen peptides. This invention allows for the accurate determination of amino-terminal procollagen peptide (type III) in body fluids, which is crucial for various medical assessments. Another significant patent focuses on N,N'-bis(alkoxyalkyl)-pyridine-2,4-dicarboxylic acid diamines. These compounds are designed to inhibit proline hydroxylase and lysine hydroxylase, making them suitable as fibrosuppressants and immunosuppressants.

Career Highlights

Volkmar Gunzler-Pukall has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and biotechnology sectors. His work at Hoechst has allowed him to explore innovative solutions that address critical health challenges. His contributions have been recognized within the scientific community, further establishing his reputation as a leading inventor.

Collaborations

Throughout his career, Gunzler-Pukall has collaborated with esteemed colleagues such as Ekkehard Baader and Martin Bickel. These collaborations have fostered a productive environment for innovation and have led to the development of groundbreaking technologies in their respective fields.

Conclusion

Volkmar Gunzler-Pukall's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence medical diagnostics and therapeutic strategies, showcasing the importance of innovation in improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…